Since joining the Food and Drug Administration in 1986, Dr. Janet Woodcock has raised the standard of excellence in drug safety and patient care. She played a lead role in streamlining and ensuring transparency in the drug review process, helped to provide unprecedented opportunities for consumer and patient participation, as well as launched initiatives to improve drug safety management both within and outside the FDA. Dr. Woodcock has worked at the FDA’s Center for Drug Evaluation and Research since 1994. From 2005 to 2008, she served the FDA’s Commissioner, holding positions including Deputy Commissioner and Chief Medical Officer, Deputy Commissioner for Operations, and Chief Operating Officer. Before joining CDER, she served as Director of the Office of Therapeutics Research and Review and Acting Deputy Director in FDA’s Center for Biologics Evaluation and Research.